Eric A Nepute Dc Llc alias Dr. Cellular Scare

Eric A Nepute Dc Llc is not licensed or approved by Missouri State Board of Chiropractic Examiners to advertise Cold hands and feet are a potential diagnostic flag for a serious underlying condition beyond Raynaud's. as within their scope of practice.

Cold hands and feet are a potential diagnostic flag for a serious underlying condition beyond Raynaud's.

Supports

Cold hands and feet are recognized as a symptom that can reflect a range of conditions, including but not limited to Raynaud’s phenomenon, peripheral artery disease, hypothyroidism, anemia, diabetes-related neuropathy, and autoimmune diseases such as systemic sclerosis and lupus, which can be serious if untreated.^{[4][6][7][8][9][10]} Raynaud’s phenomenon itself is often divided into primary (usually benign) and secondary forms, the latter commonly associated with connective tissue diseases like systemic sclerosis, which are serious and can lead to tissue damage and digital ulcers.^[2][7][15] Cold hypersensitivity in the hands and feet has been described as a symptom that patients frequently report, and expert surveys in Korean medicine highlight that it is actively treated and considered clinically meaningful, indicating that clinicians view it as more than just a trivial complaint.^[13] A systematic review and meta-analysis of herbal medicines for cold hypersensitivity in the hands and feet shows that persistent cold symptoms are a target of therapeutic trials, implying they are clinically relevant and may be associated with broader health issues.^[6] The differential diagnosis literature on cold extremities emphasizes that clinicians must systematically evaluate for vascular occlusion (including acute limb ischemia), hematologic malignancies, cryoglobulinemia, and endocrine disease, all of which can be serious underlying conditions beyond primary Raynaud’s.^[6] Major clinical guidance on the differential diagnosis of cold hands and feet stresses that while many causes are benign, this symptom can be an early flag for peripheral arterial disease, autoimmune connective tissue disease, and other systemic illness, and therefore warrants evaluation rather than dismissal.^{[4][8][9][10]}

Contradicts

There is limited direct high-quality evidence (such as large RCTs or major guidelines) that treats cold hands and feet themselves as a reliable, stand‑alone diagnostic flag specifically indicating a serious underlying disease beyond Raynaud’s; most sources describe them as a nonspecific symptom that requires context and further workup.^[4][8][10] Expert consensus on cold hypersensitivity in the hands and feet indicates that, in western medicine, this symptom is often not classified as a distinct disease entity, and many cases are attributed to constitutional or stress-related factors rather than serious pathology, underscoring that cold extremities are frequently benign.^[13] The systematic review of herbal medicines for cold hypersensitivity in the hands and feet focuses on symptom relief and does not establish that these symptoms consistently predict or signify serious systemic disease, suggesting that the evidence base for using them as a specific diagnostic flag is weak.^[6] Reviews of Raynaud’s phenomenon emphasize the need to distinguish primary from secondary forms; primary Raynaud’s is common, often benign, and may present with cold digits without any serious underlying disease, directly limiting the claim that cold hands and feet generally indicate serious pathology beyond Raynaud’s.^[2][7][15] Clinical discussions of cold hands note that conditions such as heart disease and anemia are not usually directly expressed as cold hands, though they may influence circulation, reinforcing that cold extremities alone are rarely a definitive marker of serious disease.^[4] Overall, mainstream sources treat cold hands and feet as a common and often harmless symptom that can, but does not usually, reflect serious disease, thus contradicting any implication that they are reliably a diagnostic flag for serious conditions beyond Raynaud’s.^{[4][8][9][10]}

Mainstream view

The mainstream medical view is that cold hands and feet are a common, nonspecific symptom most often related to benign causes such as primary Raynaud’s phenomenon, environmental cold exposure, or constitutional cold sensitivity, but that they can sometimes be the presenting feature of more serious conditions including peripheral arterial disease, autoimmune connective tissue disease (e.g., systemic sclerosis, lupus), endocrine disorders (e.g., hypothyroidism), hematologic disorders, or acute vascular occlusion.^{[2][4][6][7][8][9][10][13][15]} Standard practice is not to regard cold extremities alone as a diagnostic flag for serious disease; instead, clinicians assess associated features such as color change, pain, ulcers, neurologic symptoms, systemic signs (fatigue, weight change, rash, joint symptoms), and vascular findings, and then perform targeted laboratory and imaging workup to distinguish benign primary Raynaud’s or simple cold intolerance from secondary Raynaud’s and other serious pathologies.^{[2][5][6][7][8][9][10][15]} Guidelines and expert reviews on Raynaud’s and cold extremities highlight that primary Raynaud’s is common and usually benign, while secondary Raynaud’s due to systemic sclerosis or other autoimmune disease is serious and must be identified early; cold hands and feet are

In their own wordsWatch sourceArchived copy

“Cold hands and feet? Most people write it off as Raynaud’s and move on. But that symptom might be your body waving a flag for something bigger.”

Rule: RSMo 331.010(1)

Eric A Nepute Dc Llc is not licensed or approved by Missouri State Board of Chiropractic Examiners to advertise Supporting the body at the cellular level is a treatment that guarantees real healing. as within their scope of practice.

Supporting the body at the cellular level is a treatment that guarantees real healing.

Supports

There is evidence that some therapies act at the cellular level and can significantly improve healing outcomes in specific, well‑defined conditions, but this is far from a universal guarantee of “real healing. ^[9][10][11] ” Cell‑based treatments such as autologous keratinocyte or fibroblast therapies, stromal vascular fraction cells, and platelet‑based interventions have demonstrated higher complete wound‑closure rates and faster healing in randomized or controlled studies of chronic and diabetic wounds compared with standard care, indicating that targeted cellular support can substantially enhance healing in a subset of patients and wounds. Systematic and narrative reviews on cell therapy in sports medicine and wound healing describe mechanistic plausibility (cell replacement, paracrine signaling, modulation of inflammation, promotion of vascular ingrowth) and multiple early phase trials showing improved healing metrics or structural repair in some orthopedic and wound-healing applications, supporting the idea that cellular-level interventions can promote tissue repair in certain contexts. Major reviews of stem cell therapy and cellular therapeutics report promising results for specific indications (e. ^[12] g. , hematopoietic stem cell transplantation for blood cancers, experimental use in cardiac repair, neuroprotection, and skin/cartilage regeneration), again suggesting that supporting or manipulating cells can contribute meaningfully to healing in carefully selected diseases under controlled conditions.

Contradicts

The influencer’s claim that cellular-level support is a treatment that “guarantees” real healing is not supported by high‑quality evidence and conflicts with mainstream scientific understanding, which emphasizes variable and often uncertain outcomes. ^[9][10] Trials and reviews of cell therapies and autologous blood products consistently highlight a paucity of rigorous randomized controlled trials, heterogeneous study designs, and limited long‑term data, leading to the conclusion that while potential is significant, there is still a major need for high‑quality evidence and no consensus that these therapies reliably produce healing across conditions or patients. Even in areas with apparently strong wound‑healing results, reported complete healing rates are less than 100% in some groups, and outcomes depend on wound type, comorbidities, and treatment protocols; these data show improvement in probabilities of healing, not guarantees of success for every patient. ^[11] Broad overviews of stem cell therapy and regenerative medicine explicitly state that, outside a few established uses such as hematopoietic stem cell transplantation, most stem‑cell and cellular therapies remain investigational, with inconsistent results and insufficient large‑scale trial evidence, directly contradicting any claim of guaranteed healing. ^[12]

Mainstream view

The mainstream medical and scientific view is that cellular-level mechanisms are fundamental to healing and that some targeted cellular or regenerative therapies can substantially improve outcomes in specific, well‑defined conditions, but these interventions do not guarantee real healing and remain limited, experimental, or uncertain for many diseases. ^[9][10][11] Standard practice relies on evidence‑based therapies (pharmacologic treatments, surgery, radiation, established biologics, and guideline‑directed chronic disease management) whose benefits and limits are quantified in clinical trials, recognizing that even highly effective treatments (including cell therapies) have failure rates, partial responses, and relapses. Authoritative reviews on cell therapy in wound healing and sports medicine, as well as broader surveys of stem cell and regenerative treatments, frame these approaches as promising but still evolving, with a need for more robust randomized trials, standardized protocols, and long‑term safety and efficacy data before they can be considered routine, predictable cures. ^[12] Accordingly, mainstream experts reject absolute language such as “guarantees healing” and instead describe cellular-level support as one component of a probabilistic, multifactorial healing process influenced by disease type, patient factors, and treatment quality. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsWatch sourceArchived copy

“Support your body at the cellular level, and real healing follows.”

Rule: RSMo 331.010(1)